Lynda Chin

Lynda Chin is a renowned cancer genomic scientist and physician, known for her leadership in applying technology, AI/ML, and big data to medicine, driving innovation in healthcare and cancer research. After completing her medical degree from Albert Einstein College of Medicine in 1993 and postgraduate clinical and scientific training, Lynda Chin joined the Dana–Farber Cancer Institute in 1999 as a distinguished member of its Department of Medical Oncology. During this period, she also held a professorship in Dermatology at Harvard Medical School and served as a Senior Associate Member of the Broad Institute. As principal researcher of the Genome Data Analysis Center, she played a pivotal role in The Cancer Genome Atlas (TCGA) project.

In recognition of her groundbreaking research, she received the Lila and Murray Gruber Memorial Cancer Research Award in 2014. A prolific contributor to scientific literature, Chin has authored or co-authored over 200 peer-reviewed publications and delivered more than 300 national and international conference presentations, including a notable appearance at Tedmed. Currently, she continues to drive innovation in healthcare and cancer research as the co-founder and CEO of Apricity Health, a precision oncology company dedicated to applying advanced technology, AI/ML, and big data to medicine. Her work consistently pushes the boundaries of personalized medicine, aiming to deliver transformative solutions to patients worldwide.